- Synergistic Anti-Tumor Effect of Pegylated Recombinant Human Hyaluronidase (PEGrHuPH20) with Cytotoxic Agents following Intravenous Administration in a Hormone Refractory Prostate Cancer Xenograft Model (PDF)
- Pharmacokinetics and Glucodynamics of an Insulin Analog and Regular Insulin Injected with Recombinant Human Hyaluronidase: Fast-Acting Insulins Made Faster (PDF)
- Intravenous Administration of Recombinant Human Hyaluronidase (rHuPH20) Modulates Tumor Interstitial Fluid Pressure and Pericellular Hyaluronan in a Human Prostate Carcinoma Xenograft Model (PDF)
- PEGPH20: PEGylated Human Recombinant PH20 Hyaluronidase Shows Significant Antitumor Activity Concomitant with Hyaluronan Reduction in the PC3 Hormone Refractory Prostate Cancer Model (PDF)
- Accelerated Insulin Pharmacokinetics and Improved Glycemic Control in T1DM Patients by Coadministration of Prandial Insulin with Recombinant Human Hyaluronidase (PDF)
- Accelerated Insulin Pharmacokinetics and Improved Glycemic Control in T1DM Patients by Coadministration of Prandial Insulin with Recombinant Human Hyaluronidase - Part 2 EASD 2009 (PDF)
- Accelerated Insulin Pharmacokinetics and Improved Glycemic Control in T2DM Patients by Coinjection of Prandial Insulin with Hyaluronidase - ADA 2010 (PDF)
